AliExpress, a subsidiary of BABA-W (09988.HK), released a poster with a “boxing duel” theme, displaying two boxing gloves, one black and one red, clashing violently, with the caption “See You in Hangzhou on January 7”.

The red and black boxing gloves in the poster correspond to the brand colors of AliExpress and Amazon, respectively, suggesting that AliExpress is openly challenging Amazon, Chinese media reported, citing industry insiders.

AliExpress will purportedly hold a Brand Globalization Conference in Hangzhou on January 7, 2026, inviting mainly large sellers who stock up for overseas markets. Meanwhile, Amazon's annual merchant conference had been previously held in Hangzhou.
~



AAStocks Financial News
Web Site: www.aastocks.com

HONG KONG, Dec. 24, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces that the Company has made a major oilfield discovery of Qinhuangdao 29-6 in the shallow Neogene formations of the Bohai Sea, which adds over a hundred million tons of oil equivalent in-place.

Qinhuangdao 29-6 Oilfield is located in central Bohai Sea. The main oil-bearing play is Neogene Minghuazhen Formation, characterized by shallow burial depth. The oil property is medium-heavy crude. The discovery well was drilled and completed at a depth of 1,688 meters, which encountered a total of 66.7 meters oil pay zones and was tested to produce approximately 2,560 barrels of crude oil per day. Through continued exploration, the proved in-place volume of Qinhuangdao 29-6 Oilfield has exceeded 100 million tons of oil equivalent.

Mr. Xu Changgui, the Chief Geologist of the Company, said, "CNOOC Limited has made a significant discovery through enhanced research on hydrocarbon migration and accumulation models in shallow Neogene slope zones, coupled with technological innovation. This achievement challenges the conventional understanding that slope areas merely serve as pathways for hydrocarbons rather than sites for substantial accumulation. It further highlights the considerable exploration potential of uplifted peripheral slopes in settings influenced by intense extensional–strike-slip faulting."

Qinhuangdao 29-6 Oilfield is the second one-hundred-million-ton-class lithological oilfield discovered in the mature exploration area of the Shijiutuo Uplift, further highlighting the value of fine exploration and consolidating the resource base for increasing reserves and production for the Company.

— End —

Notes to Editors:

More information about the Company is available at https://www.cnoocltd.com.

*** *** *** ***

This press release includes forward looking information, including statements regarding the likely future developments in the business of the Company and its subsidiaries, such as expected future events, business prospects or financial results. The words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company as of this date in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate under the circumstances. However, whether actual results and developments will meet the current expectations and predictions of the Company is uncertain. Actual results, performance and financial condition may differ materially from the Company's expectations, including but not limited to those associated with macro-political and economic factors, fluctuations in crude oil and natural gas prices, the highly competitive nature of the oil and natural gas industry, climate change and environmental policies, the Company's price forecast, mergers, acquisitions and divestments activities, HSSE and insurance policies and changes in anti-corruption, anti-fraud, anti-money laundering and corporate governance laws and regulations.

Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations.

*** *** *** ***

For further enquiries, please contact:

Ms. Cui Liu
Media & Public Relations
CNOOC Limited
Tel: +86-10-8452-6641
Fax: +86-10-8452-1441
E-mail: [email protected] 

Mr. Cheng Yao
Ever Bloom (HK) Communications Consultants Group Limited
Tel：+852 5540 0725
Fax：+852 2111 1103
Email: [email protected] 

香港2025年12月24日 /美通社/ -- 中國海洋石油有限公司（「公司」或「中國海油」，香港聯交所股票代碼：00883（港幣櫃台）及80883（人民幣櫃台），上海證券交易所股票代碼：600938）今天宣佈在渤海海域新近系淺層獲得秦皇島29-6億噸級油田發現。

秦皇島29-6油田位於渤海中部海域，主力含油層系為新近系明化鎮組下段，埋藏淺，油品性質為中-重質原油。該油田發現井鑽遇油層66.7米，完鑽井深1,688米，經測試，日產原油2,560桶。通過持續勘探，實現秦皇島29-6油田探明石油地質儲量超1億噸油當量。

公司總地質師徐長貴先生表示：「中國海油加强新近系淺層斜坡帶油氣運聚模式及技術創新並獲得重大發現，突破了斜坡帶油氣過路而不留、難以規模富集的傳統認識，展示了伸展—走滑斷裂强烈活動背景下凸起圍斜區的巨大勘探潜力。」

秦皇島29-6油田是石臼坨凸起勘探老區發現的第2個億噸級岩性油田，進一步彰顯了精細勘探的價值，為公司增儲上產夯實資源基礎。

— 完 —

編者注：

如需瞭解中國海洋石油有限公司更多信息，請登錄公司網站https://www.cnoocltd.com

*** *** *** ***

本新聞稿包含公司的前瞻性資料，包括關於本公司和其附屬公司業務相當可能有的未來發展的聲明，例如預期未來事件、業務展望或財務結果。「預期」、「預計」、「繼續」、「估計」、「目標」、「持續」、「可能」、「將會」、「預測」、「應當」、「相信」、「計劃」、「旨在」等詞匯以及相似表達意在判定此類前瞻性聲明。這些聲明以本公司在此日期根據其經驗以及對歷史發展趨勢，目前情況以及預期未來發展的理解，以及本公司目前相信的其它合理因素所做出的假設和分析為基礎。然而，實際結果和發展是否能夠達到本公司的目前預期和預測存在不確定性。實際業績、表現和財務狀況可能與本公司的預期產生重大差異，這些因素包括但不限於宏觀政治及經濟因素、原油和天然氣價格波動有關的因素、石油和天然氣行業高競爭性的本質、氣候變化及環保政策因素、公司價格前瞻性判斷、併購剝離活動、HSSE及保險安排、以及反腐敗反舞弊反洗錢和公司治理相關法規變化。

因此，本新聞稿中所做的所有前瞻性聲明均受這些謹慎性聲明的限制。本公司不能保證預期的業績或發展將會實現，或者即便在很大程度上得以實現，本公司也不能保證其將會對本公司、其業務或經營產生預期的效果。

*** *** *** ***

如有進一步查詢，請聯絡：

劉  翠
媒體/公共關係
中國海洋石油有限公司
電話：+86-10-8452-6641
傳真：+86-10-8452-1441
電郵：[email protected]  

程  遙
九富（香港）財訊公關集團有限公司
電話: +852 5540 0725
傳真: +852 2111 1103
電郵：[email protected] 

US bourse started lower but trended higher on Tuesday as the market absorbed the US 3Q GDP annual growth rate of 4.3%, which beat expectations. The DJIA finished up 79 points or 0.2%, at 48,442. Led by Nvidia (NVDA.US), the Nasdaq concluded 133 points or 0.6% higher, at 23,561. The S&P 500 ended up 31 points or 0.5%, at 6,909, marking a historic closing high.

Techs traded mixed. Nvidia soared 3%. Amazon (AMZN.US) and Alphabet (GOOG.US) gained over 1%. Apple (AAPL.US) went up 0.5%. Tesla (TSLA.US) dipped 0.7%. Oracle (ORCL.US) retreated 1.5%.

Novo Nordisk (NVO.US) rallied 7.3% as its oral weight-loss drug received FDA greenlight.
~



AASTOCKS Financial News
Website: www.aastocks.com

呫諾美林曲司氯銨膠囊是數十年來精神分裂症治療領域的首個重大進展，其創新機制有別於現有療法

呫諾美林曲司氯銨膠囊已被納入中國精神分裂症防治指南，凸顯了中國對新型治療方案的迫切需求。

上海和馬薩諸塞州劍橋2025年12月23日 /美通社/ -- 再鼎醫藥有限公司（納斯達克股票代碼：ZLAB；香港聯交所股份代號：9688）今日宣布，中國國家藥品監督管理局（NMPA）已批准呫諾美林曲司氯銨膠囊（凱捷樂®）^[1]的新藥上市申請，用於治療成人精神分裂症。呫諾美林曲司氯銨膠囊是70余年來^[2]首個獲批的具有全新作用機制的精神分裂症療法，為精神分裂症治療帶來了根本性突破。不同於傳統靶向多巴胺的抗精神病藥物的機制，呫諾美林曲司氯銨膠囊通過選擇性作用於大腦中的毒蕈鹼型乙酰膽鹼能M1和M4受體影響核心疾病通路。

精神分裂症是一種慢性且常導致殘疾的精神疾病，會影響患者的思考、感受和行為方式。精神分裂症的核心症狀包括陽性症狀（如幻覺和妄想）、陰性症狀（如動機和愉悅感缺失以及社交退縮）和認知症狀（如記憶、注意力和決策方面的缺陷）。在中國盡管已有抗精神病療法，許多患者仍面臨症狀改善不足及難以耐受的副作用問題。

再鼎醫藥總裁、全球研發負責人Rafael G. Amado博士表示：「我們很高興呫諾美林曲司氯銨膠囊獲得NMPA的批准，這標志著中國精神分裂症治療迎來突破性進展，中國約有800萬成人精神分裂症患者^[3]，許多人持續受到症狀或現有療法副作用的困擾。憑借廣泛的症狀改善作用和獨特的安全性，呫諾美林曲司氯銨膠囊有望重新定義精神分裂症的治療模式，我們期待盡快將這一變革性療法帶給患者。」

首都醫科大學附屬北京安定醫院院長、呫諾美林曲司氯銨膠囊中國Ⅲ期臨床研究的主要研究者王剛教授表示。「呫諾美林曲司氯銨膠囊是數十年來首款獲批用於治療精神分裂症的全新作用機制藥物，在改善陽性症狀、陰性症狀和認知症狀方面均展現出有效性，同時避免了其他抗精神病藥物常見的諸多不良反應，例如體重增加、高泌乳素血症以及錐體外系症狀等運動障礙，為患者提供了具有重要意義的新選擇。」

NMPA此次批准呫諾美林曲司氯銨膠囊是基於在中國開展的Ⅰ期藥代動力學研究、中國的Ⅲ期臨床研究（ZL-2701-001）以及三項全球EMERGENT臨床研究的數據支持。

今年9月，中華醫學會發布的《中國精神分裂症防治指南（2025年版）》已將呫諾美林曲司氯銨膠囊作為創新療法納入，這是該款藥物首次被收錄於國家級指南。

關於呫諾美林曲司氯銨膠囊（凱捷樂®）

呫諾美林曲司氯銨膠囊（凱捷樂®）一種口服M1/M4型毒蕈鹼乙酰膽鹼受體激動劑和毒蕈鹼受體拮抗劑的組合。其正在開發用於治療精神疾病。與目前主要靶向多巴胺或5-羥色胺受體的抗精神病藥物相比，呫諾美林可激活中樞神經系統中與這些疾病相關腦區的毒蕈鹼受體。曲司氯銨不易穿過血腦屏障，其作用於外周，可減輕外周膽鹼能激活所帶來的不良反應。

再鼎醫藥從Karuna Therapeutics（被百時美施貴寶公司收購）獲得了在大中華區（包括中國內地、中國香港、中國澳門和中國台灣地區）開發、生產和商業化呫諾美林曲司氯銨膠囊的獨家授權。

關於精神分裂症

精神分裂症是一種慢性且經常使人致殘的精神疾病，它會影響人們的思考、感受和行為方式。它包括陽性症狀（如幻覺和妄想）、陰性症狀（如動機和愉悅感缺失以及社交退縮）和認知症狀（如記憶、注意力和決策方面的缺陷）三大核心症狀，這些都會嚴重影響功能。與一般人群相比，精神分裂症患者的預期壽命縮短了10-20年。精神分裂症在全球影響近2400萬人，最常用的治療為抗精神病藥物。不幸的是，許多精神分裂症患者在接受現有抗精神病藥物治療期間，仍然會面臨陰性症狀和認知症狀療效有限，或出現體重增加、高泌乳素血症以及被稱為錐體外系綜合征的運動障礙等副作用問題。由於這些問題，大約75%的患者在18個月內停止服藥。治療中止後，可能會導致包括復發、住院和更長的緩解時間等健康影響。

中國有約800萬精神分裂症患者，但目前使用抗精神病藥物的治療方案僅能有效改善部分患者的症狀。與全球患者一樣，大中華區也迫切需要更全面、更有效、更安全的治療方案來治療精神分裂症患者。

關於再鼎醫藥

再鼎醫藥（納斯達克股票代碼：ZLAB； 香港聯交所股份代號：9688）是一家以研發為基礎、處於商業化階段的創新型生物制藥公司，總部位於中國和美國。我們致力於通過創新產品的發現、開發和商業化解決腫瘤、免疫、神經科學和感染性疾病領域未被滿足的巨大醫療需求。我們的目標是利用我們的能力和資源為人類健康帶來積極影響。

有關再鼎醫藥的更多信息，請訪問www.zailaboratory.com或關注https://x.com/ZaiLab_Global。 

再鼎醫藥前瞻性聲明

本新聞稿包含關於再鼎醫藥未來預期、計劃和展望的前瞻性陳述，包括但不限於包括但不限於有關呫諾美林曲司氯銨膠囊的開發和商業化前景及計劃；呫諾美林曲司氯銨膠囊的潛在獲益以及治療精神分裂症和其他精神及神經系統疾病的潛在療法相關的陳述。該等前瞻性陳述可能包括 「旨在」、「預計」、「認為」、「有可能」、「估計」、「預期」、「預測」、「目標」、「打算」、「可能」、「計劃」、「可能的」、「潛在」、「將」、「將會」等詞匯和其他類似表述。該等陳述構成《1995年美國私人證券訴訟改革法案》中定義的「前瞻性聲明」。前瞻性聲明並非對過往事實的陳述，亦非對未來表現的擔保或保證。前瞻性聲明基於我們截至本新聞稿發布之日的預期和假設，並且受到固有不確定性、風險以及可能與前瞻性聲明所預期的情況存在重大差異的情勢變更的影響。實際結果可能受各種重要因素的影響而與前瞻性聲明所示存在重大差異，該等因素包括但不限於：(1)我們成功商業化自身已獲批上市產品並從中產生收入的能力；(2)我們為自身的運營和業務計劃提供資金並為該等活動獲取資金的能力；(3)我們候選產品的臨床開發和臨床前開發的結果；(4)相關監管機構對我們的候選產品作出審批決定的內容和時間；(5)與在中國營商有關的風險；和 (6) 我們向美國證券交易委員會（SEC）備案的最新年報和季報以及其他報告中指出的其他因素。我們預計後續事件和發展將導致我們的預期和假設改變，但除法律要求之外，不論是出於新信息、未來事件或其他原因，我們均無義務更新或修訂任何前瞻性陳述。該等前瞻性陳述不應被視為我們在本新聞稿發布之日後任何日期的意見而加以信賴。

如需查閱公司向SEC提交的文件，請訪問公司官網www.zailaboratory.com和SEC網站www.sec.gov。 

Driven by the growth in EV registrations in Germany, Italy, Spain and other markets, new car sales in Europe recorded YoY growth for the 5h consecutive month in November, rising by 2.4% to 1.1 million units, as announced by the European Automobile Manufacturers' Association (ACEA).

In November, new car registrations for Volkswagen and Renault increased by 4.1% and 3%, while Stellantis and Tesla (TSLA.US) dropped by 2.7% and 11.8%, respectively. BYD COMPANY (01211.HK)'s new car registrations surged by 221.8%.
~


AASTOCKS Financial News
Website: www.aastocks.com

US bourse opened higher and trended higher on Monday as Thursday marks the beginning of Christmas holiday. The DJIA finished up 227 points or 0.5%, at 48,362. The Nasdaq closed up 121 points or 0.5%, at 23,428. The S&P 500 added 43 points or 0.6%, settling at 6,878.

Tesla (TSLA.US) shot up as much as 3.7% to peak at US$498.83, nearing the US$500 mark, with the day's upswing ebbing to 1.6% at US$488.73. Other major techs showed mixed trends, with Apple (AAPL.US) down 1%, Microsoft (MSFT.US) down 0.2%, and Alphabet (GOOG.US) up 0.9%.

AI stocks had a good run, with NVIDIA (NVDA.US) up 1.5%, reportedly set to start shipping H200 chips to China in mid-February; Oracle (ORCL.US) up 3.3%; and Micron (MU.US) up 4%.

Oracle founder Larry Ellison provided a US$40.4 billion guarantee for Paramount's (PSKY.US) acquisition offer for Warner Bros (WBD.US), with Paramount up 4.3% and Warner Bros also up 3.5%.
~



AASTOCKS Financial News
Website: www.aastocks.com

Google's parent company Alphabet (GOOG.US) announced on Monday that it will acquire the data center and energy infrastructure company Intersect for US$4.75 billion in cash and assume its debt.

Alphabet stated that Intersect will continue to operate independently, but this acquisition will help accelerate the deployment of more data centers and power generation capacity.

The transaction is anticipated to be completed in the first half of 2026, subject to certain conditions being met.
~



AASTOCKS Financial News
Website: www.aastocks.com

HONG KONG, Dec. 22, 2025 /PRNewswire/ -- Geely Automobile Holdings Limited ("Geely") (Hong Kong Stock Exchange: 0175) is pleased to announce that the merger of ZEEKR Intelligent Technology Holding Limited ("Zeekr") with Keystone Mergersub Limited ("Merger Sub"), an indirect wholly-owned subsidiary of Geely, pursuant to the previously announced Agreement and Plan of Merger, dated July 15, 2025, by Geely, Zeekr and Merger Sub, has been completed. As a result of the merger, Zeekr has become a privately held company and an indirect wholly-owned subsidiary of Geely.

Pursuant to Rule 12g-3 under the United States Securities Exchange Act of 1934, as amended (the "Exchange Act"), Geely has succeeded to the Section 12 registration, and Section 13(a) reporting obligations under the Exchange Act, of Zeekr. However, Geely has filed a Form 15F with the United States Securities and Exchange Commission ("SEC") to voluntarily terminate the registration of its ordinary shares and American depositary shares representing such shares under Section 12(g) as well as Geely's reporting obligations under Section 13(a) of the Exchange Act. Pursuant to Rule 12h-6 under the Exchange Act, the SEC permits a foreign private issuer to terminate the registration of a class of securities under Section 12(g) of the Exchange Act if it meets certain requirements. As a result of filing the Form 15F, Geely's reporting obligations under the Exchange Act were suspended immediately and will terminate no more than 90 days after the date hereof, barring any objections from the SEC.

About Geely

Geely is principally engaged in investment holding. The group is primarily involved in the research and development, manufacturing, and trading of automobiles, automobile parts and related components, as well as investment holding. For further information about Geely, please visit our website at http://www.geelyauto.com.hk. 

Forward Looking Statements

This press release contains forward-looking statements and forward-looking information (collectively "forward-looking information") within the meaning of applicable securities laws, including relating to our intention to terminate the registration, and our reporting obligations, in respect of our ordinary shares and American depositary shares representing such shares under the Exchange Act, and the timing thereof. The forward-looking information is based on certain key expectations and assumptions made by our management, including our assumption that the SEC will not object to our deregistration. Although we believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Geely can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. These include, but are not limited to, the risk that the SEC raises an objection to our deregistration. Our actual results, performance or achievement could differ materially from those expressed in, or implied by, the forward-looking information and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits that we will derive therefrom. Management has included the above summary of assumptions and risks related to forward-looking information provided in this press release in order to provide security holders with a more complete perspective on our future operations and such information may not be appropriate for other purposes. Readers are cautioned that the foregoing lists of factors are not exhaustive. Additional information on these and other factors that could affect our operations or financial results are included in reports on file with applicable securities regulatory authorities and may be accessed through https://www.hkexnews.hk. These forward-looking statements are made as of the date of this press release and we disclaim any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Investor Relations Contact

Tel: +852 2598 3333
Email: [email protected] 

HONG KONG, Dec. 22, 2025 /PRNewswire/ -- On 19 December 2025, the TVB ESG Awards 2025 Presentation Ceremony, hosted by Television Broadcasts Limited ("TVB"), was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with the highest accolade, the "Outstanding ESG Award", as well as awards for "Best in ESG Practices" and "Best in ESG Report".

Mr. Wong Wai Lun, Michael, GBS, JP, Deputy Financial Secretary of the Government of the Hong Kong Special Administrative Region (SAR), Mr. Siu Sai Wo, General Manager (Business Operations) of TVB and Dr. Lawrence Cheung Chi-chong, Chief Technology Officer of Hong Kong Productivity Council served as officiating guests at the awards ceremony and jointly presented the "Outstanding ESG Award" to Fosun International.

TVB pointed out that Fosun International's recognition with the "Outstanding ESG Award", "Best in ESG Practices" and "Best in ESG Report" is well-deserved. After more than 30 years of development, Fosun has developed into a large global company with operations spanning healthcare, tourism, consumption, and insurance. With a robust global industrial ecosystem, Fosun operates responsibly in over 40 countries and regions, actively contributing to public welfare and creating sustainable value worldwide.

TVB highlighted that the awards recognize Fosun International's outstanding performance in environmental, social, and governance (ESG) and sustainability, while affirming its excellent achievements in ESG over the past year. Each award is presented to the top three scorers in their respective categories, with organizations excelling in both "ESG Practices" and "ESG Report" eligible for the highest accolade, the "Outstanding ESG Award".

In addition to Fosun International, other recipients of TVB's highest accolade, the "Outstanding ESG Award", are all organizations that have demonstrated excellence in ESG. These include government statutory bodies, major public utilities, and well-known companies such as the Airport Authority Hong Kong, MTR Corporation, Schneider Electric, China State Construction Development Holdings Limited, and Riskory Consultancy Limited.

Ms. Angel Sze, Company Secretary and Head of ESG Management Committee of Fosun International, accepted the "Outstanding ESG Award" on behalf of the company and subsequently joined representatives from other award-winning organizations in a panel discussion to share Fosun International's ESG practices and achievements.

Driven by innovation, committed to social contribution

During the discussion, Angel Sze remarked, "Fosun remains committed to innovation-driven development and globalization. Since its establishment, Fosun has stayed true to its original aspiration of 'Contribution to Society', striving to create positive societal impact through its operations. Taking our Health segment as an example, we target original innovation to address unmet clinical needs. By continuously strengthening our independent R&D and innovation capabilities, we strive to deliver higher-quality, more accessible, and more affordable medicines and services to patients."

Fosun adheres to an innovation-driven strategy, and the anticancer drugs developed by its Health segment have widely benefited cancer patients. Among them, HANSIZHUANG, an innovative anti-PD-1 monoclonal antibody independently developed by Fosun, is the world's first anti-PD-1 monoclonal antibody approved for the first-line treatment of small cell lung cancer (SCLC). To date, it has been approved for marketing in nearly 40 countries and regions, including China, the European Union, the United Kingdom, Singapore, and India.

Since the beginning of this year, Fosun has achieved multiple breakthroughs in the field of innovative drugs. HLX43, a PD-L1-targeting antibody-drug conjugate (ADC), is undergoing clinical studies for solid tumors such as non-small cell lung cancer and thymic carcinoma in countries including China, the United States, and Australia. Currently, no PD-L1 ADC has been approved globally, positioning HLX43 as a potential highly effective and safe broad-spectrum anticancer drug.

On 7 December, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security (MOHRSS) released the 2025 national medical insurance drug list, which includes multiple marketed products from Fosun Pharma. Moreover, the highly anticipated inaugural edition of the commercial insurance innovative drug list was unveiled, featuring Fosun Pharma's CAR-T cell therapy Yi Kai Da (ejilunsai injection). The successful inclusion of innovative drugs underscores national support for pharmaceutical innovation and paves the way for market promotion and patient access.

Fosun's innovation capabilities have also received high recognition from global pharmaceutical companies. On 9 December, Fosun Pharma announced that its subsidiary had entered into a license agreement with Pfizer, granting Pfizer exclusive worldwide license for the development, use, manufacturing, and commercialization of oral small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonists, including YP05002, and any products containing such oral small molecule GLP-1R agonists as an active ingredient.

At the same time, Fosun actively integrates global resources to accelerate the introduction of cutting-edge medical technologies in China, enhancing the accessibility and affordability of medical technologies. By the end of September 2025, over 480 Da Vinci surgical systems had been installed in more than 370 hospitals across the Chinese mainland, Hong Kong SAR, and Macau SAR, collectively serving over 810,000 patients.

Centering on "Health" as a global public issue, Fosun launched the Rural Doctors Program in 2017. Since its launch, the Program has supported 25,000 rural doctors and benefited 3 million rural families. It was honored as one of the United Nations Global Compact's "20 Cases of Private Sector's Sustainable Development in China for 20 Years", earning international recognition as a model for empowering rural healthcare.

Actively responding to climate change and attaching great importance to biodiversity conservation

With climate change being one of the most severe long-term risks, Fosun recognizes the importance of global cooperation to tackle this challenge. Fosun remains committed to advancing China's "dual carbon" goals by promoting carbon neutrality and energy conservation and emission reduction. In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement.

The Group also actively encourages its member companies to carry out climate actions. In 2024, the Bund Finance Center (BFC), the Group's main office location in Shanghai and a landmark in Shanghai, was successfully included in Shanghai's first batch of carbon peaking and carbon neutrality pilot demonstration projects, becoming the only large-scale commercial complex exceeding 200,000 square meters on the list.

In 2024, Fidelidade, Fosun's insurance company in Portugal, established the Impact Center For Climate Change (ICCC), a knowledge center dedicated to climate change research. Through collaborations with external entities, including universities, research centers, and public institutions, it provides scientific insights on the impacts of climate change on society, particularly in the insurance industry.

In addition to actively addressing climate change, Fosun also places great importance on biodiversity conservation. Since 2018, the Lost Chambers Aquarium at Atlantis Sanya, a subsidiary of Fosun Tourism Group (FTG), has been dedicated to rescuing and rehabilitating sea turtles in Hainan Province and its surrounding waters. As of 2024, the aquarium had rescued 24 sea turtles and held 6 sea turtle release events since its opening, returning 10 rehabilitated turtles to the ocean.

On 28 November, FTG hosted "Fosun Holiday Horizon 2026" at Atlantis Sanya, where it signed a partnership agreement with the Nanjing Institute of Environmental Sciences (NIES) of the Ministry of Ecology and Environment (MEE). The two parties will incorporate biodiversity conservation and habitat creation into Club Med resorts, jointly developing China's first "biodiversity resort" centered on the concept of "harmonious coexistence between humans and nature".

Empowering a sustainable future through globalization and innovation

Looking ahead, Fosun will remain focused on its core businesses, step up innovation efforts, and firmly advance its globalization strategy, creating greater value for shareholders, employees and society. At the same time, Fosun will continue to closely follow global sustainability trends, continuously refine its ESG management, actively respond to national strategies, ensure information security, promote technology innovation, implement "dual carbon" goals, participate in public welfare undertakings, and protect employees' rights and interests. Leveraging the resources and advantages of its global industrial ecosystem, Fosun endeavors to make a greater impact on sustainable development and continuously contribute to a better world.